Archive: Diana Laird joins Department of OB/GYN & Reproductive Sciences
New UCSF Faculty, June 2009
University of California San Francisco
Displaying 12931 - 12960 of 16701
-
-
Archive: Supervisor Introduces Helipad Resolution for Rapid Transport of Critically Ill
San Francisco Supervisor Sophie Maxwell introduced a resolution on June 9 that, if passed, will allow for the operation of a helipad at the new UCSF Medical Center at Mission Bay.
-
Archive: Sacramento forum to focus on impact of global health on California
-
Archive: San Jose Mercury News story on gene sequencing features comment by Chancellor-Designate
-
Archive: Diabetes management study targeting Chinese Americans covered in SF Chronicle, Chinese Press
-
Archive: Enzyme is culprit in neuronal death after stroke and brain trauma
The death of neurons in stroke and brain trauma is caused by the malfunctioning of a cell signaling system that normally plays a part in laying down memories, according to a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
-
Archive: Three to Receive Chancellor's Award for Gay, Lesbian, Bisexual, and/or Transgender Leadership
The campus community is invited to honor three individuals who will receive the 2009 Chancellor’s Award for Gay, Lesbian, Bisexual and/or Transgender Leadership on June 10.
-
Archive: Nursing School Dean Honored with "Distinguished Career" Award
Dean Kathleen Dracup has received one of the highest honors bestowed by the American Association of Critical-Care Nurses, commemorating nearly 40 years of teaching, research and patient care.
-
Archive: Patients see benefit from investigational therapy for auto-inflammatory syndrome
UCSF Associate Clinical Professor of Dermatology Kieron Leslie, MD, is co-author of a new journal article on treatment for cryopyrin-associated periodic syndrome, or CAPS, a rare and potentially life-threatening auto-inflammatory disease. The disorder can cause fatigue, fever, and chronic anemia from infancy, with inflammation to the skin, eyes, and bones or joints. Data from the paper “Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome," appearing in the June 4, 2009 edition of the <i>New England Journal of Medicine</i>, show that patients in a recently completed one-year Phase III clinical trial experienced a benefit within hours of receiving a dose of canakinumab, and only needed further treatment every two months to control their disease. The success of the therapy in blocking inflammation and its related symptoms could lead to investigation of the drug’s potential use for treating gout, rheumatoid arthritis, and type 2 diabetes.
-
Archive: National and local media feature opening of Helen Diller Family Cancer Research Building
-
Archive: Human Genome Pioneer Talks Personalized Medicine at UCSF Mission Bay
Four visionary leaders from science, industry and venture capital discussed the future of cancer research at the opening of the Helen Diller Family Cancer Research Building at Mission Bay.
-
Archive: Goal of Personalized Medicine for Cancer Goes Mainstream
Four experts discussed progress, hopes and challenges related to personalized cancer treatment Tuesday at UCSF’s new Helen Diller Family Cancer Research Building on the Mission Bay campus.
-
Archive: Quest to Conquer Cancer Continues in New Research Building at Mission Bay
Faculty, staff, friends and supporters gathered Tuesday for the opening of the Helen Diller Family Cancer Research Building, the fourth research facility to open on the Mission Bay campus.
-
Archive: HIV cardiovascular risk equal to risk from diabetes, study finds
HIV infection increases the risk of atherosclerosis – hardening and thickening of the arteries from plaque – by the same amount that traditional risk factors such as diabetes or smoking do, according to a study led by researchers from the San Francisco VA Medical Center and the University of California, San Francisco.
-
Archive: UCSF Celebrates Grand Opening of Helen Diller Family Cancer Research Building at Mission Bay
UCSF officially opened the Helen Diller Family Cancer Research Building on its Mission Bay campus today with a ribbon-cutting and open house highlighting a new vision for cancer research, treatment, and prevention.
-
Archive: UCSF to Mark Opening of Helen Diller Family Cancer Research Building
The opening of a new cancer research building tomorrow at Mission Bay represents the “manifestation of a vision our outstanding cancer specialists have been working toward for more than a decade,” says Chancellor Mike Bishop.
-
Archive: I-SPY trial offers key insights into locally advanced breast cancer
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. One finding offers a critical message regarding treatment strategy, they say.
-
Archive: Cancer Center Aims to Advance Medical Care Worldwide
By conducting biomedical research, shaping health care policy, and educating future generations of researchers and caregivers, UCSF aims to advance cancer treatment worldwide, says cancer center Director Frank McCormick.
-
Archive: New Ad Campaign Promotes UCSF's Cancer Expertise
UCSF Medical Center is launching a web-based ad campaign to raise awareness of its expertise in cancer research and care.
-
Archive: Scientists Begin Moving into Helen Diller Family Cancer Research Building
UCSF scientists have begun moving into the Helen Diller Family Cancer Research Building, which will bring together approximately 410 cancer researchers.
-
Archive: SF Chronicle profiles Helen Diller and her support for UCSF
-
Archive: Stage Is Set for Education Reform, US Secretary Says at UCSF
US Secretary of Education Arne Duncan and Children’s Defense Fund President Marian Wright Edelman visited UCSF recently, saying that education may finally be getting the funds it deserves to repair the country’s broken school system.
-
Archive: UCSF discovers new glucose-regulating protein linked with diabetes
Researchers at the University of California, San Francisco, and collaborators at Harvard Medical School have linked a specialized protein in human muscles to the process that clears glucose out of the bloodstream, shedding light on what goes wrong in type 2 diabetes on a cellular level.
-
Archive: The Scientist features Brodsky research on glucose-regulating proteins
-
Archive: Grumbach to Receive Cone Award for Community Partnerships
UCSF’s Kevin Grumbach will receive an award today for excellence in cultivating community partnerships in higher education.
-
Archive: Cancer research partnership between UCSF, MMRF to drive drug development
The University of California, San Francisco (UCSF) and the Multiple Myeloma Research Foundation (MMRF) have established the Stephen and Nancy Grand Multiple Myeloma Translational Initiative, a research collaboration dedicated to translating basic science discoveries into new candidate drugs for testing in clinical trials.
-
Archive: New Initiative at UCSF Targets Multiple Myeloma
The Multiple Myeloma Translational Initiative (MMTI) aims to promote collaborative research efforts and accelerate the transition of promising cancer therapies from the lab to the hospital.
-
Archive: SF Chronicle, KQED, KCBS cover NIH Women's Health Summit
-
Archive: After Rigorous Research Fellowship, UCSF Students Unveil Their Findings
Tackling health threats and improving quality of life were clearly goals that this year’s student researchers had in mind when selecting their projects, which they presented May 19 at a symposium in Millberry Union.
-
Archive: MAY 30 seminar educates families with inherited heart rhythm disorders
A special seminar at UCSF on Saturday, May 30, will focus on educating patients and families with inherited heart rhythm disorders about advancements in genetic research and treatment and the potential risks to these patients posed by certain medications and athletic activity.